DNA

Insider Trades

Name	Value	Action	Price	Current Price
Coen Steven P.See Remarks $2.6k307 shares SellMay 22, 2026 $8.33 --
Coen Steven P.See Remarks $2.6k324 shares SellApr 17, 2026 $7.95 --
Coen Steven P.See Remarks $213k33.2k shares SellApr 13, 2026 $6.41 --
Canton Barry10 Percent Owner $802k124.7k shares SellApr 10, 2026 $6.43 --
Shetty Reshma P.Director, 10 Percent Owner, Officer: See Remarks $802k124.7k shares SellApr 10, 2026 $6.43 --
Kelly Jason RDirector, Officer: See Remarks $702k109.8k shares SellApr 9, 2026 $6.40 --

News

seekingalpha.comFTAI Aviation: Innovation Is Their DNAseekingalpha.comJun 7

businesswire.comIntegrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insightsbusinesswire.comJun 1

businesswire.comTempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfoliobusinesswire.comMay 29

prnewswire.comGinkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discoveryprnewswire.comMay 26

prnewswire.comPositive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in Chinaprnewswire.comMay 21

Trade DNA

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.

CEO: Jason Kelly
IPO Date: Apr 19, 2021

Market Data

Open: $8.66
High: $9.20
Low: $8.66
Volume: 1.5M
Avg Volume: 1.3M
52W High: $17.58
52W Low: $5.37

Valuation

Market Cap: $599M
Enterprise Value: $866M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-179M
Revenue: $170M
Net Income: $-313M
Cash: $167M
Debt: $440M

Events

EarningsAug 6

EPS est. -1.04813